Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.5
2.7
Journals
Antibodies
Announcements
share announcement

Announcements

20 August 2025
Antibodies | Notable Review Papers Published in 2023–2024


Given that all articles published in Antibodies (ISSN: 2073-4468) are freely available in an open access format, we welcome you to read our notable review papers published in 2023 and 2024.

1. “CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases”
by Sara Gómez-Melero and Javier Caballero-Villarraso
Antibodies 2023, 12(2), 30; https://doi.org/10.3390/antib12020030
Available online: https://www.mdpi.com/2073-4468/12/2/30

2. “Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria”
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
Antibodies 2024, 13(1), 21; https://doi.org/10.3390/antib13010021
Available online: https://www.mdpi.com/2073-4468/13/1/21

3. “A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)”
by Kristin Widyasari and Jinnam Kim
Antibodies 2023, 12(1), 5; https://doi.org/10.3390/antib12010005
Available online: https://www.mdpi.com/2073-4468/12/1/5

4. “Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy”
by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
Antibodies 2023, 12(3), 46; https://doi.org/10.3390/antib12030046
Available online: https://www.mdpi.com/2073-4468/12/3/46

5. “Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier”
by Toshihiko Tashima
Antibodies 2023, 12(3), 43; https://doi.org/10.3390/antib12030043
Available online: https://www.mdpi.com/2073-4468/12/3/43

6. “Non-Affinity Purification of Antibodies”
by Tsutomu Arakawa, Yui Tomioka, Masataka Nakagawa, Chiaki Sakuma, Yasunori Kurosawa, Daisuke Ejima, Kouhei Tsumoto and Teruo Akuta
Antibodies 2023, 12(1), 15; https://doi.org/10.3390/antib12010015
Available online: https://www.mdpi.com/2073-4468/12/1/15

7. “New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond”
by Marino Paroli, Chiara Gioia and Daniele Accapezzato
Antibodies 2023, 12(1), 25; https://doi.org/10.3390/antib12010025
Available online: https://www.mdpi.com/2073-4468/12/1/25

8. “IgA Nephropathy: Current Treatment and New Insights”
by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
Antibodies 2023, 12(2), 40; https://doi.org/10.3390/antib12020040
Available online: https://www.mdpi.com/2073-4468/12/2/40

9. “Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature”
by Maxime Taghavi, Abla Jabrane, Lucas Jacobs, Maria Do Carmo Filomena Mesquita, Anne Demulder and Joëlle Nortier
Antibodies 2024, 13(1), 1; https://doi.org/10.3390/antib13010001
Available online: https://www.mdpi.com/2073-4468/13/1/1

10. “Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management”
by Panagiotis Gklinos and Ruth Dobson
Antibodies 2024, 13(2), 43; https://doi.org/10.3390/antib13020043
Available online: https://www.mdpi.com/2073-4468/13/2/43

More News...
Back to TopTop